Review
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Stem Cells. Jun 26, 2021; 13(6): 521-541
Published online Jun 26, 2021. doi: 10.4252/wjsc.v13.i6.521
Recent trends in stem cell-based therapies and applications of artificial intelligence in regenerative medicine
Sayali Mukherjee, Garima Yadav, Rajnish Kumar
Sayali Mukherjee, Garima Yadav, Rajnish Kumar, Amity Institute of Biotechnology, Amity University Uttar Pradesh, Lucknow 226028, Uttar Pradesh, India
Author contributions: Mukherjee S and Kumar R conceived of this manuscript; Yadav G and Mukherjee S performed the literature review and initial data collection; Mukherjee S, Yadav G and Kumar R wrote the manuscript; Kumar R and Mukherjee S edited and prepared the manuscript for submission.
Conflict-of-interest statement: Authors have no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Rajnish Kumar, BPharm, MTech, PhD, Assistant Professor, Amity Institute of Biotechnology, Amity University Uttar Pradesh, Near Malhaur Railways Station, Lucknow 226028, Uttar Pradesh, India. rkumar2@lko.amity.edu
Received: February 16, 2021
Peer-review started: February 16, 2021
First decision: March 17, 2021
Revised: March 22, 2021
Accepted: May 20, 2021
Article in press: May 20, 2021
Published online: June 26, 2021
Processing time: 130 Days and 2.7 Hours
Core Tip

Core Tip: This article reviews some important types of stem cells in clinical treatment including embryonic stem cells, induced pluripotent stem cells, induced tissue-specific stem cells, and adult stem cells. Furthermore, the article focuses on the clinical treatment of mesenchymal stem cells and the application of artificial intelligence in induced pluripotent stem cells, their limitations, and future prospects.